On the horizon: pathways for drug development in Alzheimer's disease

Clin Geriatr Med. 2004 Feb;20(1):141-52. doi: 10.1016/S0749-0690(03)00073-9.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / etiology
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Chemistry, Pharmaceutical / trends
  • Cholinesterase Inhibitors / adverse effects
  • Cholinesterase Inhibitors / therapeutic use*
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / therapeutic use*
  • Estrogen Replacement Therapy / adverse effects
  • Forecasting
  • Humans
  • Nootropic Agents / adverse effects
  • Nootropic Agents / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cholinesterase Inhibitors
  • Drugs, Investigational
  • Nootropic Agents